Literature DB >> 35869777

[JAG1 promotes migration, invasion, and adhesion of triple-negative breast cancer cells by promoting angiogenesis].

J Liu1, Y Shi1, M Wu1, M Xu1, F Zhang1, Z He1, M Tang1.   

Abstract

OBJECTIVE: To investigate the effect of JAG1 on the malignant phenotype of triple-negative breast cancer (TNBC) and its role in angiogenesis in breast cancer microenvironment.
METHODS: The expressions of Notch molecules were detected in human TNBC 231 and 231B cells using RT-qPCR. Five female nude mice were inoculated with 231 cells and another 5 with 231B cells into the mammary fat pads, and 4-6 weeks later, the tumors were collected for immunohistochemical and immunofluorescence tests. 231 cells and 231B cells were treated with recombinant JAG (rJAG) protein and DAPT, respectively, and changes in their malignant phenotypes were assessed using CCK-8 assay, Hoechst 33258 staining, wound healing assay, Transwell chamber assay and endothelial cell adhesion assay. Western blotting was used to detect the changes in the expressions of proteins related with the malignant phenotypes of 231 and 231B cells. The effects of conditioned medium (CM) derived from untreated 231 and 231 B cells, rJAG1-treated 231 cells and DAPT-treated 231B cells on proliferation and tube formation ability of cultured human umbilical vein endothelial cells (HUVECs) were evaluated using CCK-8 assay and tube-forming assay.
RESULTS: The expression of JAG1 was higher in 231B cells than in 231 cells (P < 0.05). Tumor 231B showed higher expression of VEGFA and CD31. Compared with 231-Blank group, the migration, invasion and adhesion of 231 cells in 231-rJAG1 were significantly enhanced (P < 0.05). Protein levels of Twist1 and Snail increased (P < 0.01), anti-apoptotic protein Bcl-2 increased (P < 0.05), while DAPT inhibited the related phenomena and indicators of 231B. The 231-rJAG1-CM increased the cell number and tubule number of HUVEC (P < 0.05).
CONCLUSION: JAG1 may affect the malignant phenotype of TNBC and promote angiogenesis in the tumor microenvironment.

Entities:  

Keywords:  JAG1; angiogenesis; triple-negative breast cancer; tumor microenvironment; vascular endothelial cell growth factor-A

Mesh:

Substances:

Year:  2022        PMID: 35869777      PMCID: PMC9308863          DOI: 10.12122/j.issn.1673-4254.2022.07.21

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  40 in total

1.  Expression of Jagged1/Notch3 Signaling Pathway and their Relationship with the Tumor Angiogenesis in TNBC.

Authors:  Siliang Xue; Lang He; Xiao Zhang; Jin Zhou; Fanghua Li; Xiaoshan Wang
Journal:  Arch Med Res       Date:  2017-02       Impact factor: 2.235

2.  Potential Involvement of Jagged1 in Metastatic Progression of Human Breast Carcinomas.

Authors:  Natalia Bednarz-Knoll; Antonia Efstathiou; Frauke Gotzhein; Harriet Wikman; Volkmar Mueller; Yibin Kang; Klaus Pantel
Journal:  Clin Chem       Date:  2015-12-31       Impact factor: 8.327

3.  IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland.

Authors:  Pasquale Sansone; Gianluca Storci; Simona Tavolari; Tiziana Guarnieri; Catia Giovannini; Mario Taffurelli; Claudio Ceccarelli; Donatella Santini; Paola Paterini; Kenneth B Marcu; Pasquale Chieco; Massimiliano Bonafè
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

4.  Delta-like ligand 4 (DLL4) in the plasma and neoplastic tissues from breast cancer patients: correlation with metastasis.

Authors:  Emmanuel Kontomanolis; Marianthi Panteliadou; Alexandra Giatromanolaki; Stamatia Pouliliou; Eleni Efremidou; Vassilios Limberis; Georgios Galazios; Efthimios Sivridis; Michael I Koukourakis
Journal:  Med Oncol       Date:  2014-04-03       Impact factor: 3.064

5.  Exome sequencing revealed Notch ligand JAG1 as a novel candidate gene for familial exudative vitreoretinopathy.

Authors:  Lin Zhang; Xiang Zhang; Huijuan Xu; Lulin Huang; Shanshan Zhang; Wenjing Liu; Yeming Yang; Ping Fei; Shujin Li; Mu Yang; Peiquan Zhao; Xianjun Zhu; Zhenglin Yang
Journal:  Genet Med       Date:  2019-07-05       Impact factor: 8.822

6.  An isoflavone derivative potently inhibits the angiogenesis and progression of triple-negative breast cancer by targeting the MTA2/SerRS/VEGFA pathway.

Authors:  Xiaotong Zhang; Gengyi Zou; Xiyang Li; Lun Wang; Tianyu Xie; Jin Zhao; Longlong Wang; Shunchang Jiao; Rong Xiang; Haoyu Ye; Yi Shi
Journal:  Cancer Biol Med       Date:  2020-08-15       Impact factor: 4.248

Review 7.  Relevance of Notch Signaling for Bone Metabolism and Regeneration.

Authors:  Tobias M Ballhause; Shan Jiang; Anke Baranowsky; Sabine Brandt; Peter R Mertens; Karl-Heinz Frosch; Timur Yorgan; Johannes Keller
Journal:  Int J Mol Sci       Date:  2021-01-29       Impact factor: 5.923

8.  Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway.

Authors:  Sushil Kumar; Ajeya Nandi; Snahlata Singh; Rohan Regulapati; Ning Li; John W Tobias; Christian W Siebel; Mario Andres Blanco; Andres J Klein-Szanto; Christopher Lengner; Alana L Welm; Yibin Kang; Rumela Chakrabarti
Journal:  Nat Commun       Date:  2021-01-18       Impact factor: 14.919

9.  Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis.

Authors:  Serena Mancarella; Grazia Serino; Francesco Dituri; Antonio Cigliano; Silvia Ribback; Jingxiao Wang; Xin Chen; Diego F Calvisi; Gianluigi Giannelli
Journal:  Cell Death Differ       Date:  2020-02-10       Impact factor: 15.828

10.  Notch3 inhibits epithelial-mesenchymal transition in breast cancer via a novel mechanism, upregulation of GATA-3 expression.

Authors:  Hao-Yu Lin; Yuan-Ke Liang; Xiao-Wei Dou; Chun-Fa Chen; Xiao-Long Wei; Jing-Wen Bai; Yu-Xian Guo; Fang-Fang Lin; Wen-He Huang; Cai-Wen Du; Yao-Chen Li; Min Chen; Guo-Jun Zhang
Journal:  Oncogenesis       Date:  2018-08-13       Impact factor: 7.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.